Instituto Nacional de Estadística. Available at: http://www.ine.es. Accessed March 2012.
World Health Organization, HIV/AIDS: Global Situation and Trends. Available at: http://www.who.int. Accessed March 2012.
Documento de Consenso de GESIDA/Plan Nacional Sobre el SIDA Sobre el Tratamiento Antirretroviral del Adulto (Actualización de Enero 2011). Available at: http://www.gesida.seimc.org. Accessed March 2012.
Recomendaciones de GESIDA/PNS/AEEH Sobre Tratamiento y Manejo del Paciente Adulto Coinfectado por VIH y Virus de Hepatitis A, B y C (Septiembre 2009). Available at: http://www.gesida.seimc.org. Accessed March 2012.
González-Martín J, García-García JM, Anibarro L, Vidal R, Esteban J, Blanquer R, Moreno S, Ruiz-Manzano J, 2010. Consensus document on the diagnosis, treatment and prevention of tuberculosis. Enferm Infecc Microbiol Clin 28: e1–20.
Karp CL, Auwaerter PG, 2007. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens. Clin Infect Dis 45: 1209–1213.
Karp CL, Auwaerter PG, 2007. Coinfection with HIV and tropical infectious diseases. II. Helminthic, fungal, bacterial and viral pathogens. Clin Infect Dis 45: 1215–1220.
Lawn SD, Wilkinson RJ, 2006. Immune reconstitution disease associated with parasitic infections following antiretroviral treatment. Parasite Immunol 28: 625–633.
Riera C, Verges M, Iniesta L, Fisa R, Gállego M, Tebar S, Portús M, 2012. Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera. Am J Trop Med Hyg 86: 412–416.
Rougemont M, Van Saanen M, Sahli R, Hinrikson HP, Bille J, Jaton K, 2004. Detection of four Plasmodium species in blood from humans by 18 S rRNA gene subunit-based and species-specific real-time PCR assays. J Clin Microbiol 42: 5636–5643.
Lillie PJ, Bazaz R, Greig JM, 2008. Screening African HIV positive1patients for imported parasitic infections. J Infect 57: 481–484.
Sarner L, Fakoya AO, Tawana C, Allen E, Copas AJ, Chiodini PL, Fenton KA, 2007. The utility of screening for parasitic infections in HIV-1-infected Africans with eosinophilia in London. Int J STD AIDS 18: 626–629.
Lescure FX, le Loup G, Freilij H, Develoux M, Paris L, Brutus L, Pialoux G, 2010. Chagas disease: changes in knowledge and management. Lancet Infect Dis 10: 556–570.
Sartori AM, Ibrahim KY, Nunes Westphalen EV, Braz LMA, Oliveira OC, Gakiya E, Lopes MH, Shikanai-Yasuda MA, 2007. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 101: 31–50.
Rodríguez-Guardado A, Asensi-Álvarez V, Rodríguez-Pérez M, Mejuto-Álvarez P, Flores-Chávez M, Alonso-González P, Cartón-Sánchez JA, 2011. Screening for Chagas disease in HIV-positive immigrants from endemic areas. Epidemiol Infect 139: 539–543.
Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, Gradoni L, Horst RT, López-Vélez R, Moreno J, 2008. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334–359.
Medrano FJ, Cañavate C, Leal M, Rey C, Lissen E, Alvar J, 1998. The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1. Am J Trop Med Hyg 59: 155–162.
Flateau C, Le Loup G, Pialoux G, 2011. Consequences of HIV infection on malaria and therapeutic implications: a systematic review. Lancet Infect Dis 11: 541–556.
Matisz CE, Naidu P, Shokoples SE, Grice D, Krinke V, Brown SZ, Kowalewska-Grochowska K, Houston S, Yanow SK, 2011. Post-arrival screening for malaria in asymptomatic refugees using real-time PCR. Am J Trop Med Hyg 84: 161–165.
Ross AGP, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, McManus DP, 2002. Schistosomiasis. N Engl J Med 346: 1212–1220.
Karanja DM, Colley DG, Nahlen BL, Ouma JH, Secor WE, 1997. Studies on schistosomiasis in western Kenia. I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg 56: 515–521.
Keiser PB, Nutman TB, 2004. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17: 208–217.
Siddiqui AA, Berck SL, 2001. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33: 1040–1047.
Bon B, Houze S, Talabani H, Magne D, Belkadi G, Develoux M, Senghor Y, Chandenier J, Ancelle T, Hennequin C, 2010. Evaluation of a rapid enzyme-linked immunosorbent assay for diagnosis of Strongyloidiasis. J Clin Microbiol 48: 1716–1719.
Biggs B-A, Caruana S, Mihrshahi S, Jolley D, Leydon J, Chea L, Nuon S, 2009. Short report: management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful? Am J Trop Med Hyg 80: 788–791.
Sanyaolu AO, Oyibo WA, Fagbenro-Beyioku AF, Gbadegeshin AH, Iriemenam NC, 2011. Comparative study of entero-parasitic infections among HIV sero-positive and sero-negative patients in Lagos, Nigeria. Acta Trop 120: 268–272.
Modjarrad K, Zulu I, Redden DT, Njobvu L, Freedman DO, Vermund SH, 2005. Prevalence and predictors of intestinal helminth infections among human immunodeficiency virus type 1-infected adults in an urban African setting. Am J Trop Med Hyg 73: 777–782.
Lewthwaite P, Gill GV, Hart CA, Beeching NJ, 2005. Gastrointestinal parasites in the immunocompromised. Curr Opin Infect Dis 18: 427–435.
Hochberg NS, Moro RN, Sheth AN, Montgomery SP, Steurer F, McAuliffe IT, Wang YF, Armstrong W, Rivera HN, Lennox JL, Franco-Paredes C, 2011. High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States. PLoS Negl Trop Dis 5: e1034.
World Health Organization, Schistosomiasis: Key Points and Geographical Distribution. Available at: http://www.who.int. Accessed March 2012.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 708 | 474 | 14 |
Full Text Views | 834 | 9 | 0 |
PDF Downloads | 186 | 12 | 0 |
Latent parasitic infections can reactivate because of immunosuppression. We conducted a prospective observational study of all human immunodeficiency virus (HIV)–infected immigrants who visited the Infectious Diseases Department of the Hospital Universitari Vall d'Hebron, Barcelona, Spain, during June 2010–May 2011. Screening of the most prevalent tropical diseases (intestinal parasitosis, Chagas disease, leishmaniasis, malaria, schistosomiasis, and strongyloidiasis) was performed according to geographic origin. A total of 190 patients were included: 141 (74.2%) from Latin America, 41 (21.6%) from sub-Saharan Africa, and 8 (4.2%) from northern Africa. Overall, 36.8% (70 of 190) of the patients had at least one positive result for any parasitic disease: 5 patients with positive Trypanosoma cruzi serology, 11 patients with positive Schistosoma mansoni serology, 35 patients with positive Strongyloides stercoralis serology, 7 patients with positive Leishmania infantum serology, intestinal parasitosis were detected in 37 patients, malaria was diagnosed in one symptomatic patient. We propose a screening and management strategy of latent parasitic infections in immigrant patients infected with HIV.
Financial support: This study was partially supported by Red Temática de Investigación en SIDA (RIS G03/173-RETIC RD06/0006/0039).
Disclosure: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Authors' addresses: Fernando Salvador, Israel Molina, Elena Sulleiro, Joaquín Burgos, Adrián Curran, Eva Van den Eynde, Sara Villar del Saz, Jordi Navarro, Manuel Crespo, Inma Ocaña, Esteve Ribera, Vicenç Falcó, and Albert Pahissa, Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain, E-mails: fmsalvad@vhebron.net, imolina@vhebron.net, esulleiro@vhebron.net, jburgos@vhebron.net, acurran@vhebron.net, evdeyne@vhebron.net, svillar@vhebron.net, jnavarro@vhebron.net, mcrespo@vhebron.net, iocana@vhebron.net, eribera@vhebron.net, vfalco@vhebron.net, and apahissa@vhebron.net.
Instituto Nacional de Estadística. Available at: http://www.ine.es. Accessed March 2012.
World Health Organization, HIV/AIDS: Global Situation and Trends. Available at: http://www.who.int. Accessed March 2012.
Documento de Consenso de GESIDA/Plan Nacional Sobre el SIDA Sobre el Tratamiento Antirretroviral del Adulto (Actualización de Enero 2011). Available at: http://www.gesida.seimc.org. Accessed March 2012.
Recomendaciones de GESIDA/PNS/AEEH Sobre Tratamiento y Manejo del Paciente Adulto Coinfectado por VIH y Virus de Hepatitis A, B y C (Septiembre 2009). Available at: http://www.gesida.seimc.org. Accessed March 2012.
González-Martín J, García-García JM, Anibarro L, Vidal R, Esteban J, Blanquer R, Moreno S, Ruiz-Manzano J, 2010. Consensus document on the diagnosis, treatment and prevention of tuberculosis. Enferm Infecc Microbiol Clin 28: e1–20.
Karp CL, Auwaerter PG, 2007. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens. Clin Infect Dis 45: 1209–1213.
Karp CL, Auwaerter PG, 2007. Coinfection with HIV and tropical infectious diseases. II. Helminthic, fungal, bacterial and viral pathogens. Clin Infect Dis 45: 1215–1220.
Lawn SD, Wilkinson RJ, 2006. Immune reconstitution disease associated with parasitic infections following antiretroviral treatment. Parasite Immunol 28: 625–633.
Riera C, Verges M, Iniesta L, Fisa R, Gállego M, Tebar S, Portús M, 2012. Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera. Am J Trop Med Hyg 86: 412–416.
Rougemont M, Van Saanen M, Sahli R, Hinrikson HP, Bille J, Jaton K, 2004. Detection of four Plasmodium species in blood from humans by 18 S rRNA gene subunit-based and species-specific real-time PCR assays. J Clin Microbiol 42: 5636–5643.
Lillie PJ, Bazaz R, Greig JM, 2008. Screening African HIV positive1patients for imported parasitic infections. J Infect 57: 481–484.
Sarner L, Fakoya AO, Tawana C, Allen E, Copas AJ, Chiodini PL, Fenton KA, 2007. The utility of screening for parasitic infections in HIV-1-infected Africans with eosinophilia in London. Int J STD AIDS 18: 626–629.
Lescure FX, le Loup G, Freilij H, Develoux M, Paris L, Brutus L, Pialoux G, 2010. Chagas disease: changes in knowledge and management. Lancet Infect Dis 10: 556–570.
Sartori AM, Ibrahim KY, Nunes Westphalen EV, Braz LMA, Oliveira OC, Gakiya E, Lopes MH, Shikanai-Yasuda MA, 2007. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 101: 31–50.
Rodríguez-Guardado A, Asensi-Álvarez V, Rodríguez-Pérez M, Mejuto-Álvarez P, Flores-Chávez M, Alonso-González P, Cartón-Sánchez JA, 2011. Screening for Chagas disease in HIV-positive immigrants from endemic areas. Epidemiol Infect 139: 539–543.
Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, Gradoni L, Horst RT, López-Vélez R, Moreno J, 2008. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334–359.
Medrano FJ, Cañavate C, Leal M, Rey C, Lissen E, Alvar J, 1998. The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1. Am J Trop Med Hyg 59: 155–162.
Flateau C, Le Loup G, Pialoux G, 2011. Consequences of HIV infection on malaria and therapeutic implications: a systematic review. Lancet Infect Dis 11: 541–556.
Matisz CE, Naidu P, Shokoples SE, Grice D, Krinke V, Brown SZ, Kowalewska-Grochowska K, Houston S, Yanow SK, 2011. Post-arrival screening for malaria in asymptomatic refugees using real-time PCR. Am J Trop Med Hyg 84: 161–165.
Ross AGP, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, McManus DP, 2002. Schistosomiasis. N Engl J Med 346: 1212–1220.
Karanja DM, Colley DG, Nahlen BL, Ouma JH, Secor WE, 1997. Studies on schistosomiasis in western Kenia. I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg 56: 515–521.
Keiser PB, Nutman TB, 2004. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17: 208–217.
Siddiqui AA, Berck SL, 2001. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33: 1040–1047.
Bon B, Houze S, Talabani H, Magne D, Belkadi G, Develoux M, Senghor Y, Chandenier J, Ancelle T, Hennequin C, 2010. Evaluation of a rapid enzyme-linked immunosorbent assay for diagnosis of Strongyloidiasis. J Clin Microbiol 48: 1716–1719.
Biggs B-A, Caruana S, Mihrshahi S, Jolley D, Leydon J, Chea L, Nuon S, 2009. Short report: management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful? Am J Trop Med Hyg 80: 788–791.
Sanyaolu AO, Oyibo WA, Fagbenro-Beyioku AF, Gbadegeshin AH, Iriemenam NC, 2011. Comparative study of entero-parasitic infections among HIV sero-positive and sero-negative patients in Lagos, Nigeria. Acta Trop 120: 268–272.
Modjarrad K, Zulu I, Redden DT, Njobvu L, Freedman DO, Vermund SH, 2005. Prevalence and predictors of intestinal helminth infections among human immunodeficiency virus type 1-infected adults in an urban African setting. Am J Trop Med Hyg 73: 777–782.
Lewthwaite P, Gill GV, Hart CA, Beeching NJ, 2005. Gastrointestinal parasites in the immunocompromised. Curr Opin Infect Dis 18: 427–435.
Hochberg NS, Moro RN, Sheth AN, Montgomery SP, Steurer F, McAuliffe IT, Wang YF, Armstrong W, Rivera HN, Lennox JL, Franco-Paredes C, 2011. High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States. PLoS Negl Trop Dis 5: e1034.
World Health Organization, Schistosomiasis: Key Points and Geographical Distribution. Available at: http://www.who.int. Accessed March 2012.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 708 | 474 | 14 |
Full Text Views | 834 | 9 | 0 |
PDF Downloads | 186 | 12 | 0 |